Safety, Tolerability and Immunogenicity of a Plant-made H7 Virus-like Particle (VLP) Influenza Vaccine in Adults.
Phase of Trial: Phase I
Latest Information Update: 19 Dec 2018
Price : $35 *
At a glance
- Drugs Influenza A vaccines (Primary) ; Aluminium hydroxide
- Indications Influenza A virus infections
- Focus Adverse reactions; Pharmacodynamics
- Sponsors Medicago
- 24 Sep 2015 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov.
- 04 Sep 2014 Planned End Date changed from 1 Aug 2014 to 1 Dec 2014 as reported by ClinicalTrials.gov record.
- 04 Sep 2014 Planned primary completion date changed from 1 Apr 2014 to 1 Sep 2014 as reported by ClinicalTrials.gov record.